Clinical trial
Osteoporotic Precisely Screening Using Chest Radiograph and Artificial Neural Network (OPSCAN): a Randomized Controlled Trial
NCT05721157 is registered in ClinicalTrials.gov with National Defense Medical Center, Taiwan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Osteoporotic Precisely Screening Using Chest Radiograph and Artificial Neural Network (OPSCAN): a Randomized Controlled Trial
- Lead sponsor
- National Defense Medical Center, Taiwan
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 1, 2023
- Completion date
- June 30, 2023
- Enrollment
- 4,912 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.